Updates are available Correction dated 2025-11-10
Click to view Correction: https://doi.org/10.1038/s41375-025-02811-3
-
Authors
Suto, Keito https://orcid.org/0000-0001-8212-5664
Takei, Norio
Yokoyama, Keito
Chiba, Masahiro https://orcid.org/0000-0003-2731-6091
Ishio, Takashi
Maeda, Michiyuki
Goto, Hideki
Endo, Tomoyuki
Teshima, Takanori https://orcid.org/0000-0002-0941-271X
Yang, Yibin https://orcid.org/0000-0002-9948-8696
Nakagawa, Masao https://orcid.org/0000-0002-8602-6054
-
Funding
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (JP21H02775)
MEXT | Japan Society for the Promotion of Science (23K15314)
Takeda Pharmaceutical Company (NA)
Princess Takamatsu Cancer Research Fund (NA)
U.S. Department of Health & Human Services | National Institutes of Health (R01 CA259188)
U.S. Department of Health & Human Services | National Institutes of Health (R01 CA251674)
American Cancer Society (RSG-23-722314)
Leukemia and Lymphoma Society (NA)
- License Information
-
More Information
Article History
Received: 19 March 2024
Revised: 9 October 2024
Accepted: 11 October 2024
First Online: 21 October 2024
Change Date: 5 November 2025
Change Type: Update
Change Details: The original online version of this article was revised: The BV concentration units were incorrectly labeled as pM due to an error in molar conversion. The correct unit used in all experiments was nM. This labeling error appears in the following sections: Figures: 1D, 2A, 2B, 2C, 2F Supplementary Figures: 1A, 1D, 3B, 4G, 5B, 5C Supplementary Materials and Methods: Genome-wide CRISPR library screen The original article has been corrected.
Change Date: 10 November 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41375-025-02811-3
Competing interests
: MN received research funding from Takeda Pharmaceutical Company Limited. The other authors declare no competing financial interests related to this work.
